(Date:11/20/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue. ,, Medical Adhesives and Sealants - A U...om/p0164242/Medical-Adhesives-and-Sealants---A-US-...edium=pr&utm_campaign=prnewswire ,, The u...eeminence in medical devices and equipments. Cutti...
(Date:11/20/2009)...v. 20 BD (Becton, Dickin...e completion of its acquisition of HandyLab, Inc.,...s and manufactures molecular diagnostic assays and...andyLab announced an exclusive agreement for BD to... HandyLab Jaguar(TM) platform, the first fully int...
(Date:11/19/2009)...RNewswire/ -- In response to an ever-increasing nu...edicines, Operation Pangea II, involving 24 countr...lth Organization,s International Medical Products ...t the dangers of buying medicines online. ,, Th... of arrests and the seizure of thousands of potent...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2First Potential Lupus Specific Treatment in Sight 4744 1First Potential Lupus Specific Treatment in Sight 4744 2First Potential Lupus Specific Treatment in Sight 4744 3Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 1Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 2Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 3Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 4Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 5Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 6Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 7Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 8Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 9Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 10Waging War on Wrinkles 3A Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport The Botox Alternative 52054 1Waging War on Wrinkles 3A Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport The Botox Alternative 52054 2...NCETON, N.J., Dec. 11 Pharmasset, Inc.,(Nasdaq: ...ommitted to,discovering, developing and commercial...ted financial results for the fiscal year ended Se... held $63.6 million in cash and cash,equivalents a... and 2008 Highlights , Clevudine , Dur...
... VEGAS, Dec. 11 CardioVascular BioTherapeutics, I...t two additional hospitals in the United States op... clinical trial for the treatment of severe corona...Institute Foundation in Minneapolis MN, and Prince... , Mercy Hospital Fairfield (Ohio) and The Chri...
Other Medicine Technology:Pharmasset Reports Fiscal Year End 2008 Financial Results 2Pharmasset Reports Fiscal Year End 2008 Financial Results 3Pharmasset Reports Fiscal Year End 2008 Financial Results 4Pharmasset Reports Fiscal Year End 2008 Financial Results 5Pharmasset Reports Fiscal Year End 2008 Financial Results 6Pharmasset Reports Fiscal Year End 2008 Financial Results 7Pharmasset Reports Fiscal Year End 2008 Financial Results 8Pharmasset Reports Fiscal Year End 2008 Financial Results 9CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial 2(Date:11/22/2009)...p eating under control, expert says , , ...ason means you,ll be faced with a seemingly endles...ply give in and eat too much, others deny themselv...navigate between overindulgence and deprivation, a...nsult Services at Brigham and Women,s Hospital in ...
(Date:11/21/2009).... 21 Tonight, in a part...ator Reid,s version of the government takeover of ... included in this bill; like the public option, em...funding for elective abortion, which is the most o... bill provides subsidies for private plans that co...
(Date:11/21/2009)...scusses Key Provisions of Legislation, Continues P...CHARLES, Ill., Nov. 21 ...he landmark Affordable Health Care for America Act...orm legislation forward, Congress has taken decisi...stem. Today, AARP hosted an educational forum to ...
(Date:11/21/2009)...ric J. Hall, president and chief executive officer...sued the following statement regarding the inclusi...e new annual wellness for Medicare beneficiaries i... Act" that was introduced last night: , ...21, 2009 -- Eric J. Hall, president and chief exec...
(Date:11/20/2009)...v. 20 The American Aca...health care reform legislation released this week ...surance individual coverage mandate. The actuaries...ll minimize adverse selection stemming from more r...e bill. ,, "The individual mandate language sho...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2...c Comments on Comparative Effectiveness Research P... April 7 The Federal Coordinating Council for Com... listening session on April 14, 2009, in Washingto...ministration is committed to openness and transpar...
...ge-scale testing after ,very promising, early resu... -- A new drug with a radically different way of a...al trial and is ready for larger-scale testing, re...ive tumor growth. Existing anti-androgens try to "...
...ries more than usual care, study finds, , ...adults, anxiety is an increasingly common problem,... therapy may help them ease their worries more tha...sive symptoms and improved general mental health a...
...ession of alcohol, zero tolerance prevent more tha...Y, April 7 (HealthDay News) -- Not all laws are cr...f drinking-related auto accidents, say researchers...se and possession of alcohol by youth, including u...
... Clinic researchers have discovered the mechanisms...elopment factors that may ultimately allow invest... stop them from further development. The findings ...ctivated kinase 2 (PAK2), a key target for cancer ...
... BioInformatics, LLC announces the pending releas...rtunities for Stem Cell Products. As a result of...ns on federal funding of human embryonic stem cell...n this report, BioInformatics, LLC ( http://www....
Other Medicine News:Health News:Federal Coordinating Council on Comparative Effectiveness Research to Hold Public Listening Session in Washington, DC 2Health News:New Prostate Cancer Drug May Hold Promise 2Health News:New Prostate Cancer Drug May Hold Promise 3Health News:Cognitive Behavior Therapy Eases Anxiety for Older People 2Health News:Cognitive Behavior Therapy Eases Anxiety for Older People 3Health News:Tough Legislation on Underage Drinking Seems to Save Lives 2Health News:Tough Legislation on Underage Drinking Seems to Save Lives 3Health News:Mayo researchers discover mechanism of cell type-specific signaling in tumor development 2Health News:BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products 2Health News:BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products 3...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: